Your session is about to expire
← Back to Search
Procedure
esolution catheter for Atrial Fibrillation
N/A
Waitlist Available
Research Sponsored by S4 Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15-72 hours post-ablation procedure
Awards & highlights
Study Summary
This study is evaluating whether deviating the esophagus will reduce/eliminate ablation injury to the esophagus.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 15-72 hours post-ablation procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15-72 hours post-ablation procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of esophageal injury attributable to RF ablation energy as noted on post ablation endoscopy
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Interventional GroupExperimental Treatment1 Intervention
Placement of a luminal esophageal temperature probe (LET) and insertion of esolution esophageal retractor. In the intervention group, esolution will be utilized to deviate the esophagus during RF catheter ablation
Group II: Control GroupActive Control1 Intervention
Placement of a luminal esophageal temperature probe (LET) during RF ablation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
esolution catheter
2021
N/A
~130
Find a Location
Who is running the clinical trial?
S4 MedicalLead Sponsor
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger